Catecholamines reduce choice history biases in perceptual decision making
PLOS Biology · 2025
DOI: 10.1371/journal.pbio.3003361 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Jan Willem de Gee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Decision Making, Catecholamines, Choice Behavior. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amsterdam Brain and Cognition, German Research Foundation, Dutch Research Council.
Abstract (Originalsprache)
Theoretical accounts postulate that the catecholaminergic neuromodulator noradrenaline shapes cognition and behavior by reducing the impact of prior expectations on learning, inference, and decision-making. A ubiquitous effect of dynamic priors on perceptual decisions under uncertainty is choice history bias: the tendency to systematically repeat, or alternate, previous choices, even when stimulus categories are presented in a random sequence. Here, we directly test for a causal impact of catecholamines on these priors. We pharmacologically elevated catecholamine levels in human participants through the application of the noradrenaline reuptake inhibitor atomoxetine. We quantified the resulting changes in observers’ history biases in a visual perceptual decision task. Choice history biases in this task were highly idiosyncratic, tending toward choice repetition or alternation in different individuals. Atomoxetine decreased these biases (toward either repetition or alternation) compared to placebo. Behavioral modeling indicates that this bias reduction was due to a reduced bias in the accumulation of sensory evidence, rather than of the starting point of the accumulation process. Atomoxetine had no significant effect on other behavioral measures tested, including response time and choice accuracy. Atomoxetine and variations of pupil-linked arousal at slower and faster timescales had analogous effects on choice history bias. We conclude that catecholamines reduce the impact of a specific form of prior on perceptual decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Cognitive and Systems Neuroscience, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Brain & Cognition, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Psychology, University of Lübeck, Lübeck, Germany.
- Center of Brain, Behavior and Metabolism, University of Lübeck, Lübeck, Germany.
- Max Planck Institute for Human Development, Berlin, Germany.
ORCID-Profile: Jan Willem de Gee
Förderung
- Amsterdam Brain and Cognition
- German Research Foundation
- Dutch Research Council
- Deutsche Forschungsgemeinschaft
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
de Gee, J. W., Kloosterman, N. A., Braun, A., & Donner, T. H. (2025). Catecholamines reduce choice history biases in perceptual decision making. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003361
Vancouver
de Gee JW, Kloosterman NA, Braun A, Donner TH. Catecholamines reduce choice history biases in perceptual decision making. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003361
BibTeX
@article{deGee2025,
author = {de Gee, Jan Willem and Kloosterman, Niels A and Braun, Anke and Donner, Tobias H},
title = {Catecholamines reduce choice history biases in perceptual decision making},
journal = {PLOS Biology},
year = {2025},
doi = {10.1371/journal.pbio.3003361}
}
EUVIMED